Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.024 | 0.9 |
mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.9 |
mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.019 | 0.9 |
mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.9 |
mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.9 |
mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |